Neuralink Advances to Human Trials for Brain-Implant Technology

Neuralink, the brain-implant technology company founded by Elon Musk, is seeking participants for its upcoming human clinical study. The company recently gained FDA approval for human trials and secured $280m in funding. Neuralink aims to develop a brain-computer interface that can restore independence to individuals with quadriplegia caused by spinal cord injury or ALS.

Is your Wi-Fi speed being murdered? The common mistake all BT broadband users must check today

Moving Towards Human Trials

Neuralink has obtained the necessary approvals from an independent institutional review board to conduct its first-ever human clinical trials. Over the course of six years, the study will assess the safety and efficacy of the brain implant, known as N1, and the company's surgical robot, R1. The initial goal is to enable individuals to control a computer cursor or keyboard using their thoughts through the brain-computer interface.

A Disturbing Bug in a Popular Android App Has Led Google to Take Drastic Action: Check Your Phone Now!

Creating Autonomy for Patients

Neuralink's study represents a significant step towards developing a universal brain interface that can address the unmet medical needs of individuals with disabilities. The R1 Robot will be used to carefully insert the N1 Implant's ultra-fine and flexible threads into the region of the brain responsible for movement intention. The implant, which remains invisible to the naked eye, wirelessly records and transmits brain signals to an app that decodes the intended movements.

Phones LTD Offers Samsung S23 Ultra EE Deals with Complimentary Galaxy Watch5

FDA Approval and Funding

In May, Neuralink received FDA approval for its clinical trials through an investigational device exemption. This clearance allows the company to gather safety and effectiveness data during the study. Neuralink recently raised $280m in a Series D funding round led by Founders Fund, a VC firm co-founded by billionaire tech investor Peter Thiel.

Discover the Samsung S23 Ultra EE Deals with Phones LTD: Don't Miss the Chance to Receive a Complimentary Galaxy Watch5!

A History of Innovation

Established in 2016, Neuralink has been at the forefront of brain-computer interface development. The company, headquartered in San Francisco, collaborates with experts in neuroscience and robotics to advance this field of technology. Neuralink has previously conducted successful trials with pigs and monkeys, demonstrating remarkable capabilities, such as playing the video game Pong using the N1 Link chips implanted in a monkey's brain.

While Neuralink has achieved significant milestones, it has also faced its share of controversies. The company was investigated for potential animal welfare violations, with allegations of rushed testing procedures resulting in failed experiments. Neuralink denied these claims. Additionally, the US Department of Transportation initiated an investigation into Neuralink regarding the alleged unsafe transportation of implants removed from monkey brains, citing concerns about infectious diseases.

Neuralink's upcoming human clinical trials mark a crucial step towards revolutionizing brain-implant technology and improving the lives of individuals with quadriplegia and ALS. The company is committed to creating a future where people can regain their autonomy through groundbreaking advancements. To learn more about Neuralink and its innovative work, visit their official website.